| Item 2.02. | Results of Operations and Financial Condition. |
Valera Pharmaceuticals, Inc. (the “Company”) today issued a press release reporting the Company’s financial results for the quarterly period and year ended December 31, 2006. The press release also sets forth the Company’s progress with respect to certain product milestones and identifies recent developments affecting the Company.
A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.
| Item 9.01. | Financial Statements and Exhibits. |
| (d) | Exhibit No. | Description | ||
| 99.1 | Press Release issued February 22, 2007. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| VALERA PHARMACEUTICALS, INC. | ||||||||
| Date: February 22, 2007 | By: | /s/ Andrew T. Drechsler | ||||||
| Andrew T. Drechsler Chief Financial Officer | ||||||||
Index of Exhibits
| Exhibit No. | Description | |
| 99.1* | Press Release issued February 22, 2007. |
| * | Filed herewith |
